Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- PA-25-174
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- Other
- Higher Education Inst. (Private)
- Public or Indian Housing Auth.
- Independent School Districts
- State Governments
- Special District Governments
- County Governments
- For Profit Organizations
- Tribal Organizations (Not Federally Recognized)
- Tribal Governments (Federally Recognized)
- Small Businesses
- City/Township Governments
- Non-501(c)(3) Nonprofits
- Higher Education Inst. (Public)
- 501(c)(3) Nonprofits
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Cancer Institute (NCI) is soliciting R01 research projects through the Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) grant opportunity. This funding opportunity aims to support studies that utilize state-of-the-art cancer biology methods and model systems to examine the effects of different types of radiation used in radionuclide-based cancer therapeutics on normal tissue, tumor cells, and the tumor microenvironment. Eligible applicant types include a wide range of organizations such as higher education institutions, nonprofits, and small businesses. The funding activity categories are education and health. Proposals are due on May 7, 2025.
Recent Federal Grant Awards under the related Cancer Detection and Diagnosis Research (93.394) and Cancer Treatment Research (93.395) programs have ranged from approximately $200,000 to over $1.6 million in total costs, with typical project periods spanning 2-5 years. The research is primarily conducted at recipient organizations' facilities across the United States, with some international collaboration components allowed, particularly for clinical trials networks.
Synopsis
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types of radiation used in radionuclide-based therapeutics (e.g., radiopharmaceutical therapy) on normal tissue, tumor cells and the tumor microenvironment.
Files
| File | Type | Posted |
|---|---|---|
| PA-25-174-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity